RxDoctor Payments Data

Juliana Bizerril-Williams

Medical · Bronx, NYNPI 1710310313

Payments from drug & device makers

$7,246in general payments, 2019–2025

Across 388 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1K
  • LEO Pharma Inc.$906
  • Sanofi$643
  • Regeneron Healthcare Solutions, Inc.$596
  • Dermavant Sciences, Inc.$541
  • Arcutis Biotherapeutics, Inc.$450
  • plus $3K from 17 others

What the payments were for

  • Consulting fees$2503%
  • Speaking & faculty fees$1,08015%
  • Food & beverage$5,82980%
  • Education$881%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,246 in reported general payments places this provider in the 90th percentile of 2,395 medical providers in New York.

See all medical providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
VtamaTapinarof35$47,173
JubliaEfinaconazole35$31,471
Metronidazole244$19,396
ZoryveRoflumilast17$13,703
Ivermectin35$12,795
Mometasone Furoate455$10,525
Halobetasol Propionate72$6,276
Ketoconazole376$5,508
Tacrolimus50$3,596
Clindamycin Phosphate113$3,032
Ammonium Lactate196$2,650
Calcipotriene12$2,462
Clobetasol Propionate30$2,320
Mupirocin282$1,766
Tretinoin18$1,305

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Dermavant Sciences, Inc.Vtama$541$47,17335 claims
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$71$31,47135 claims
Arcutis Biotherapeutics, Inc.Zoryve$450$13,70317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,395 medical providers in New York.

Other medical in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →